STEMI Treatment Delays Persist, Associated With Worse Outcomes – American College of Cardiology
The timely treatment of STEMI varies substantially at the hospital level, for both primary presentation and transfers, and worse outcomes were observed in patients when the first medical contact (FMC)-to-device target was not met or who presented to low-performing hospitals, according to results from a large cross-sectional study published June 11 in JAMA Cardiology. In this retrospective study, Yasser M. Sammour, MD, et al., examined site-level variability in achieving the quality metri c of FMC-to-device
